Syphilis screening in the antenatal care: a cross-sectional study from Botswana by Romoren, Maria & Rahman, Mafizur
BioMed  Central
Page 1 of 5
(page number not for citation purposes)
BMC International Health and 
Human Rights
Open Access Research article
Syphilis screening in the antenatal care: a cross-sectional study from 
Botswana
Maria Romoren*1 and Mafizur Rahman2
Address: 1Department of General Practice and Community Medicine, University of Oslo, Box 1130 Blindern, N-0318 Oslo, Norway and 2Sexual 
and Reproductive Health Associates, Gaborone, Botswana
Email: Maria Romoren* - maria.romoren@medisin.uio.no; Mafizur Rahman - mafiz@info.bw
* Corresponding author    
Abstract
Background: Congenital syphilis is recognized as a substantial public health problem in Sub-
Saharan Africa. The aim of this study was to determine the prevalence of syphilis among antenatal
care attendees in Botswana and to contribute to knowledge about the challenges facing the syphilis-
screening programme.
Methods:  In a cross-sectional study, 703 antenatal care attendees at 13 health facilities in
Gaborone, Botswana were interviewed and examined. Venous blood samples were collected for
the identification of syphilis infection. The antenatal records were used to obtain information on
any screening, diagnosis and treatment of syphilis that had been done earlier in the current
pregnancy.
Results: Active syphilis was found in 32 (5%) of the attendees. Among 546 women coming for a
repeat antenatal care visit, 71 (13%) had not been screened for syphilis. Uptake late in pregnancy,
delayed treatment and a high rate of seroconversion after testing were other identified obstacles
to the effective prevention of congenital syphilis.
Conclusion: Syphilis prevalence among pregnant women in Botswana remains high, and there is
still much to be gained by improving the effectiveness of the syphilis screening and treatment
programme. Earlier antenatal care attendance, rapid on-site testing, improved partner treatment
and a repeat test late in pregnancy to manage incident cases are important goals for patients, health
care workers and health authorities.
Background
Maternal syphilis has a severe impact on pregnancy out-
come. Although antenatal syphilis screening has proven
to be cheap and effective, syphilis during pregnancy con-
tinues to be a substantial problem in resource-poor set-
tings [1]. Published information from developing
countries reveals that there is reason to improve both the
coverage and the quality of the syphilis screening pro-
gramme in antenatal care [2-4].
In Botswana, universal screening and treatment of syphilis
in pregnancy is integrated in antenatal care. Blood is col-
lected from all attendees at the first antenatal visit and
analyzed with a non-treponemal syphilis test (the rapid
plasma reagin [RPR] test or the venereal disease research
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laboratory [VDRL] test) at a centralized laboratory.
According to the guidelines, high risk women should be
retested at 34–36 weeks of gestation. All RPR/VDRL posi-
tive cases should be provided with education, risk reduc-
tion counselling and condoms. The treatment regimen is
three doses of benzathine penicillin 2.4 million units at
weekly intervals. Partner notification and treatment is not
specifically recommended.
The striking need for improved surveillance of syphilis
and its consequences in developing countries has been
emphasized, [5] and this need is also evident in Botswana.
Unfortunately, the test results in the screening programme
are not routinely utilized to monitor the prevalence of
syphilis among antenatal care attendees. There is also a
lack of information on the proportion of pregnant
women tested, the proportion who return for their results,
treatment provided to test positive women and their part-
ners and adverse birth outcomes due to syphilis.
The aim of this study was to determine the prevalence of
syphilis among antenatal care attendees in Gaborone,
Botswana; to contribute to increased knowledge of the
implementation of the national syphilis screening pro-
gramme; and to identify areas of concern in this and sim-
ilar settings.
Methods
Included in this study were 703 antenatal care attendees
who visited 13 primary health care clinics in Gaborone,
the capital of Botswana, between October 2000 and Feb-
ruary 2001. Although 18 facilities in Gaborone provided
antenatal care at that time, the 5 facilities with less than
600 antenatal care consultations during the previous year
(range 10 to 570) were not included for practical reasons.
A proportionate sample of attendees was recruited from
each of the eligible clinics, based on the total load of ante-
natal care attendees at that clinic during the same period
in the previous year. The clinics were visited one by one,
and the attendees were consecutively invited to be
included in the study. The number of patients per day was
limited by either the total number of attendees at the
clinic that day or by the number of specimens the labora-
tory could handle (which varied from 6 to 12, due to var-
iation in staff and other activities at the lab). In the
majority of clinics, all attendees were included during the
period of data collection; in the busiest clinics only a ran-
dom sample of the attendees was included.
All participants gave written, informed consent. The only
exclusion criterion was the use of antibiotics in the two
weeks prior to their visit. No woman declined to partici-
pate in the study, but 34 attendees were excluded – 32
because of treatment for vaginal discharge syndrome and
2 because they were on penicillin for syphilis.
A structured interview was used to obtain information on
socio-demographic factors, symptoms of any sexually
transmitted infection (STI) and history of STI diagnosis
and treatment earlier in the pregnancy. All eligible attend-
ees underwent a genital examination by a medical doctor,
and clinical signs from external and internal genitalia
were recorded. For the attendees coming for a repeat visit,
we recorded the gestational age when blood was drawn
for the non-treponemal syphilis test, the test results and
the treatment prescribed, all which is documented in the
patient-held antenatal records. For study purposes, addi-
tional venous blood samples were collected from both
new and repeat attendees. The maternal sera were tested at
the National Health Laboratory with the RPR test and the
specific  Treponema pallidum haemagglutination assay
(TPHA).
Data were analyzed with the statistical package SPSS Ver-
sion 11. The study was approved by the national commit-
tees for medical research ethics in Botswana and in
Norway.
Results
The median age of the 703 antenatal care attendees was 25
years (range 15–43). Other socio-demographic character-
istics are described elsewhere [6]. Eight women reported
symptoms and five women had signs of genital ulcers, but
all of them were RPR negative. There were 157 women
coming for the first antenatal visit, with a median gesta-
tional age of 20 weeks (range 8–37). Among the 546
women coming for a repeat visit, 71 (13%) had not been
screened for syphilis in the routine antenatal programme.
Among the 475 repeat attendees who had been tested, the
median gestational age when the blood had been drawn
was 19 weeks (range 4–38). Of these 475, 14 (3%)
women had been found RPR positive during the screen-
ing. Two had not been treated; for the remaining 12
women, the mean time between blood being drawn and
treatment being prescribed was five weeks. The screening
test results for these 14 women, the treatment delay and
the syphilis serology found in the study later in pregnancy
is shown in Table 1. Among the women with negative RPR
or those lacking RPR results earlier in pregnancy, of whom
103 were in gestational week >36, none had been retested.
RPR titre and TPHA results in the study setting are shown
in Table 2. A total of 74 (11%) of the 703 attendees were
TPHA positive, indicating past or present syphilis. In all,
32 (5%) women had active syphilis (RPR+/TPHA+) and
11 (2%) had high-titre active syphilis (RPR ≥ 1:8/TPHA+).
Of the 9 repeat attendees identified in the study with high-
titre active syphilis, 1 had not been tested in the routine
screening, 3 had tested negative and 1 had tested positive
but was not treated. The last 4 had been treated (mean of
10 weeks earlier), but still had laboratory-diagnosed high-BMC International Health and Human Rights 2006, 6:8 http://www.biomedcentral.com/1472-698X/6/8
Page 3 of 5
(page number not for citation purposes)
titre syphilis, raising a concern about reinfection. Only 1
of the 17 repeat attendees identified in the study with low-
titre active syphilis had been identified in the routine
antenatal care.
We do not have data on the exact incidence of syphilis
during pregnancy, but among the 461 attendees who were
RPR negative in the routine screening, 451 were retested
in the study setting with both RPR and TPHA. Median 11
weeks later in their pregnancy, 16 (3.5%) of these 451 ini-
tially RPR negative women had active syphilis; 1 with high
and 15 with low titres. Of the 16 women, 15 reported hav-
ing had one partner the last 12 months, and 14 said that
they had been in the relationship more than two years.
Discussion
Maternal syphilis remains a significant cause of adverse
pregnancy outcome in Sub-Saharan Africa [2]. Antenatal
syphilis screening is cost-effective even at RPR prevalences
as low as 2% [7]. The syphilis prevalence in Botswana
Table 2: Syphilis prevalence among 692* antenatal care attendees in Gaborone, Botswana
New attendees n (%) Repeat attendees n (%) All attendees n (%)
RPR positive cases
RPR titre ≥8, TPHA positive (HTS) 2 (1) 9 (2) 11 (2)
RPR titre <8, TPHA positive (LTS) 4 (3) 17 (3) 21 (3)
Biologically false positive† 2 (1) 12 (2) 14 (2)
RPR negative cases
Past or treated syphilis‡ 11 (7) 31 (6) 42 (6)
Uninfected 138 (88) 466 (87) 604 (87)
Total 157 (100) 535 (100) 692 (100)
RPR, rapid plasma reagin; TPHA, Treponema pallidum haemagglutination assay; HTS, high-titre syphilis; LTS, low-titre syphilis
*Among 546 repeat attendees, 11 were excluded from this analysis because the TPHA was missing.
† TPHA-negative
‡ TPHA-positive
Table 1: Routine syphilis screening and serological status in the study setting. Results among 14 antenatal attendees who were RPR 
positive in the screening programme.
Screening programme Study setting
Routine RPR 
result
Blood drawn 
gestational week
Treatment 
gestational week
Treatment 
prescribed
Gestational week RPR result TPHA
Reactive 20 24 Standard regimen* 34 1:32 Positive
Reactive 27 - No treatment† 30 1:16 Positive
1:8 16 20 Standard regimen 32 1:16 Positive
1:16 23 25 Standard regimen 
twice
39 1:16 Positive
1:2 14 18 Standard regimen 39 1:8 Positive
Reactive 14 19 Single-dose 
penicillin
29 1:2 Positive
Reactive 20 24 Standard regimen 31 Non-reactive Positive
1:2 19 - No treatment 28 1:1 Negative
1:4 15 27 Standard regimen 38 Non-reactive Negative
1:4 25 30 Standard regimen 36 Non-reactive Negative
1:2 17 25 Single-dose 
penicillin
36 Non-reactive Negative
1:2 14 19 Single-dose 
penicillin
40 Non-reactive Negative
1:2 19 23 Standard regimen 33 Non-reactive Negative
1:4 15 19 Standard regimen 38 Non-reactive Missing
*Botswana guidelines for the management of RPR/VDRL positive cases  (regardless of titre): Three injections with benzathine penicillin 2.4  million 
units at weekly intervals. 
†The patient came for the third  antenatal care visit.BMC International Health and Human Rights 2006, 6:8 http://www.biomedcentral.com/1472-698X/6/8
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must still be considered high. In our study from Gabor-
one, 7% of the pregnant women were RPR positive. In the
national HIV/AIDS surveillance in 2003, 5% of the ante-
natal care attendees were RPR positive. In the 2005 sur-
veillance, 3% of the attendees were RPR positive [8,9].
Rural districts seem to be in special need of intensified
prevention efforts, as prevalences up to 13% were found
in less densely populated areas such as the Kalahari
Desert. A recent review of laboratory logbooks in Francis-
town, the largest town of northern Botswana, found that
the prevalence of VDRL positive antenatal care attendees
declined from 12% in 1992 to 4% in 2003 [10]. The
authors suggest that a decline in risky sexual behaviour
due to interventions to control the HIV epidemic may
have resulted in a reduced prevalence of syphilis. The
introduction of syndromic management of STIs in 1992,
which implies that 150000 to 200000 STI clients have
been treated with multiple antibiotics yearly, may also
have contributed to reduce the prevalences of curable
STIs. It is critical that data showing a possible encouraging
trend do not lead to reduced attention; rather, they should
be used as a motivator for continued and improved syph-
ilis control.
To prevent congenital syphilis, it is imperative to screen
for syphilis early in pregnancy; but this remains a chal-
lenge. We found that the pregnant women who came for
a first antenatal care visit had a median gestational age of
20 weeks. The repeat attendees had been tested at 19
weeks. Promotion of earlier attendance at antenatal care is
a simple prevention strategy which should be advocated.
The current practice of processing tests at centralized lab-
oratories also results in delayed treatment; as described, it
is takes more than a month before treatment is provided.
To ensure immediate treatment, rapid diagnosis of syphi-
lis can be introduced in the clinics, as recommended by
the World Health Organization [11]. Botswana is in a
favourable position to explore the use of such tests.
Through the prevention of mother-to-child transmission
of HIV (PMTCT) programme, all health posts and clinics
have a lay counsellor with four weeks of training who per-
forms rapid tests for HIV. Several authors have empha-
sized the need to identify synergies between the PMTCT
and the syphilis screening programmes [5,12]. To utilize
lay counsellors to perform simple, rapid point-of-care
tests for both syphilis and HIV could prove a concrete and
feasible opportunity to reduce the disease burden of these
two infections.
This study from Botswana also identifies several other
operational difficulties within the syphilis screening pro-
gramme. Of the 26 repeat attendees who were identified
with active syphilis (RPR and TPHA positive) in our study,
only five had been identified and treated with penicillin in
routine antenatal care. Not all antenatal care attendees
had been tested, and not all attendees with positive RPR
results had been treated. None of the attendees in the
study population had been routinely tested more than
once. As many as 3.5% of the women who were RPR neg-
ative in the routine screening were RPR and TPHA positive
when re-tested in the study after a median period of 11
weeks. All but one of these women was considered to be
at low risk of infection. The women's initial TPHA status
is not known, and some of them could have had old or
untreated syphilis combined with an RPR seroconversion
due to conditions other than syphilis. Nevertheless, the
results indicate a high number of incident cases, and we
recommend an urgent change in the retesting policy. A
repeat test late in pregnancy for both low- and high-risk
attendees should be clearly stated in the guidelines and
communicated to the health workers.
In the national STI management guidelines, partner noti-
fication and treatment is explicitly recommended for
other STI syndromes, but not for RPR/VDRL positive
cases. Botswana, like many other countries, relies on
patient-based partner referral, with index patients inform-
ing their own contacts and referring them for treatment.
To avoid reinfection of the patients and reduce the spread
of syphilis, partners of RPR/VDRL positive antenatal care
attendees should be treated. A patient-based contact trac-
ing strategy should be the minimum strategy employed in
the syphilis screening programme, and more intense
efforts should be considered. It is known that partner
notification and treatment can be improved by introduc-
ing combinations of provider and patient referral, and by
explicit and thorough verbal health education [13].
Our results indicate a need for improved coverage of the
screening and improved adherence to treatment guide-
lines. However, it is a limitation of the study that we do
not have information on why the guidelines are not fol-
lowed. Data on the impact of maternal syphilis on preg-
nancy outcome are also lacking. A targeted approach to
improving the syphilis screening programme requires that
more knowledge be gathered about the specific problems,
where they exist, and why. There is an obvious need to
strengthen the routine data collection. In order to evaluate
the screening programme continuously, each clinic can
easily register and report the proportion of pregnant
women who are tested and the proportion of test-positive
women who are effectively treated. Studies on the quality
of STI care in Botswana have shown that the clinics have
adequate supplies of equipment and drugs, but that
nurses' adherence to the guidelines is poor [14,15].
Informing the clinics about the prevalence of syphilis and
the screening and treatment coverage, together with in-
service training and supervision, could increase the health
care providers' commitment to the programme.Publish with BioMed Central    and   every 
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The study population is representative for antenatal care
attendees in Gaborone, and the level of health care is sup-
posed to be the same throughout the country. However,
conditions such as communication, transport, educa-
tional level and standard of living are less favourable in
the rural areas. To the best of our understanding, it is rea-
sonable to expect the same or higher prevalence of syphi-
lis, as well as the same or greater operational difficulties in
the rest of the country. We also believe that the results of
this study are of relevance to other developing countries.
Conclusion
Syphilis remains a significant public health problem in
many resource-poor settings. Lack of adequate antenatal
care has been described as an important obstacle to the
prevention of congenital syphilis globally, and available
data show that this is also the case in Botswana. The prev-
alence of syphilis among pregnant women is high, and
there is much to be gained by improving the effectiveness
of the syphilis screening and treatment programme. We
recommend promotion of earlier antenatal care attend-
ance, rapid on-site testing, improved partner treatment
and a repeat test late in pregnancy in order to manage inci-
dent cases. Increased commitment among both politi-
cians and health care workers is necessary to reduce
maternal syphilis and its consequences.
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